CD28 CTLA4-B7 INTERACTION IS DISPENSABLE FOR T-CELL STIMULATION BY MOUSE MAMMARY-TUMOR VIRUS SUPERANTIGEN BUT NOT FOR B-CELL DIFFERENTIATION AND VIRUS DISSEMINATION/
E. Champagne et al., CD28 CTLA4-B7 INTERACTION IS DISPENSABLE FOR T-CELL STIMULATION BY MOUSE MAMMARY-TUMOR VIRUS SUPERANTIGEN BUT NOT FOR B-CELL DIFFERENTIATION AND VIRUS DISSEMINATION/, European Journal of Immunology, 26(7), 1996, pp. 1595-1602
B cells are the primary targets of infection for mouse mammary tumor v
irus (MMTV). However, for productive retroviral infection, T cell stim
ulation through the virally-encoded superantigen (SAG) is necessary. I
t activates B cells and leads to cell division and differentiation. To
characterize the role of B cell differentiation for the MMTV life cyc
le, we studied the course of infection in transgenic mice deficient fo
r CD28/CTLA4-B7 interactions (mCTLA4-H gamma 1 transgenic mice). B cel
l infection occurred in CTLA4-H gamma 1 transgenic mice as integrated
proviral DNA could be detected in draining lymph node cells early afte
r infection by polymerase chain reaction analysis. In mice expressing
I-E, B cells were able to present the viral SAG efficiently to V beta
6(+) T cells. These cells expanded specifically and were triggered to
express the activation marker CD69. Further stages of progression of i
nfection appeared to be defective. Kinetics experiments indicated that
T and B cell stimulation stopped more rapidly than in control mice. B
cells acquired an activated CD69(+) phenotype, were induced to produc
e IgM but only partially switched to IgG secretion. Finally, the disse
mination of infected cells to other lymph nodes and spleen was reduced
and the peripheral deletion of V beta 6(+) T cells was minimal. In co
ntrast, in mice lacking I-E, T cell stimulation was also impaired and
B cell activation undetectable. These data implicate B7-dependent cell
ular interactions for superantigenic T cell stimulation by low-affinit
y TCR ligands and suggest a role of B cell differentiation in viral di
ssemination and peripheral T cell deletion.